Upstream Bio UPB
NASDAQ UPB
$2.87 +0.05 (+1.77%)
As of: Oct 21, 2026 · 11:41 AM EDT

Upstream Bio (UPB) Other financing activities (2024 - 2025)

Updated

Analysis

Upstream Bio (UPB) Other financing activities (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Upstream Bio 156.06 Mn -1.11 Bn -3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -34,000.00
Sep 30, 2024 -1.66 Mn
API Access

Upstream Bio Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=UPB&period=max&api_key=YOUR_API_KEY